Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Net Shares Issued and Repurchased (2019 - 2025)

Clene (CLNN) posted Net Shares Issued and Repurchased of $903743.0 for Q4 2025, up 184.68% on a QoQ basis from $317455.0 in Q1 2025, and down 7.37% year-over-year from $975671.0 in Q4 2024.

Analysis

Clene (CLNN) Net Shares Issued and Repurchased (2019 - 2025) Analysis & Trends

Clene has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $903743.0 in Q4 2025.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 7.37% year-over-year to $903743.0 in Q4 2025; TTM through Dec 2025 was $903743.0, a 7.37% decrease from a year earlier, with the FY2025 full-year figure at $903743.0, down 7.37% from the prior year.
  • Net Shares Issued and Repurchased was $903743.0 for Q4 2025 at Clene, up from $317455.0 in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $7.1 million in Q4 2023, with the low at $280070.0 in Q1 2024.
  • Average Net Shares Issued and Repurchased over 5 years is $2.5 million, with a median of $1.4 million recorded in 2021.
  • The sharpest annual moves came in 2021 and 2024: Net Shares Issued and Repurchased jumped 1334.5% in 2021, then tumbled 86.17% in 2024.
  • Over 5 years, Net Shares Issued and Repurchased stood at $3.9 million in 2021, then surged by 64.17% to $6.4 million in 2022, then increased by 10.7% to $7.1 million in 2023, then plunged by 86.17% to $975671.0 in 2024, then declined by 7.37% to $903743.0 in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $903743.0 (Q4 2025), $317455.0 (Q1 2025), and $975671.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Clene 45.69 Mn 45.69 Mn 54,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 903,743.00
Mar 31, 2025 317,455.00
Dec 31, 2024 975,671.00
Mar 31, 2024 280,070.00
Dec 31, 2023 7.05 Mn
Mar 31, 2023 1.08 Mn
Dec 31, 2022 6.37 Mn
Mar 31, 2022 2.49 Mn
Dec 31, 2021 3.88 Mn
Mar 31, 2021 1.63 Mn
Dec 31, 2020 270,555.00
Dec 31, 2019 1.44 Mn